| | Title | Authors / Editors | Date |
|
unige:32495 |
Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration |
Chatzidionysiou, Katerina; Lie, Elisabeth; Nasonov, Evgeny; Lukina, Galina; ... Gabay, Cem |
2012 |
|
unige:99458 |
Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration |
Chatzidionysiou, Katerina; Lie, Elisabeth; Nasonov, Evgeny; Lukina, Galina; ... van Vollenhoven, Ronald F |
2016 |
|
unige:21319 |
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs |
Smolen, Josef S.; Landewe, Robert; Breedveld, Ferdinand C.; Dougados, Maxime; ... van der Heijde, D. |
2010 |
|
unige:25468 |
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries |
Chatzidionysiou, Katerina; Lie, Elisabeth; Nasonov, Evgeny; Lukina, Galina; ... van Vollenhoven, Ronald F |
2011 |
|
unige:110656 |
Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration |
Chatzidionysiou, Katerina; Lie, Elisabeth; Lukina, Galina; Hetland, Merete L; ... van Vollenhoven, Ronald |
2017 |
Gomez-Reino, Juan
add all
remove all
